These data together suggested that in AD, calpain‐mediated DARPP‐32 truncation and activation of PP1 might be involved in the impairment of the PKA‐CREB signaling pathway and therefore impairing learning and memory ability in the affected subject. Here, CREB1 is linked to Alzheimer disease.